Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments
NCT01708473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-11-24
Summary
This study will compare the effectiveness of two pain medications for reducing discomfort during an Ultherapy treatment.
Conditions
- Skin Laxity
Interventions
- DRUG
-
Advil
One (1) tablet 800 mg Advil one hour prior to treatment.
- DRUG
-
Lortab
One (1) tablet 10/500 mg of Lortab one hour prior to treatment.
- DEVICE
-
Ulthera System Treatment
Focused ultrasound energy delivered below the surface of the skin
Sponsors & Collaborators
-
Ulthera, Inc
lead INDUSTRY
Principal Investigators
-
Hema Sundaram, MD · Dermatology, Cosmetic & Laser Surgery
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
Compounded Pain Creams and Patient Perception
NCT02024802 ·Status: WITHDRAWN
-
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
NCT06218784 ·Status: RECRUITING ·Phase: PHASE1
-
IV Lidocaine Infusion for Neuropathic Pain
NCT05731739 ·Status: WITHDRAWN
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
NCT01917825 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
NCT01058642 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms
NCT02497066 ·Status: COMPLETED ·Phase: PHASE3
-
First-In-Human PainCart Study for STR-324
NCT03430232 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects
NCT01401764 ·Status: COMPLETED ·Phase: PHASE1
-
OLP-1002 is Being Studied in the Treatment of Pain.
NCT03760913 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)
NCT06809569 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject
NCT02348879 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy
NCT00120120 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin
NCT03587220 ·Status: COMPLETED ·Phase: NA
-
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
NCT03372161 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
NCT05721287 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
NCT06595004 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
NCT01200524 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
NCT05096494 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers
NCT03058237 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)
NCT01842126 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
NCT01201317 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
NCT00166452 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
NCT06972212 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
NCT05496205 ·Status: COMPLETED ·Phase: PHASE1